Oncologists awareness about bisphosphonate related osteonecrosis of the jaws

ŞENTÜRK M. F., Cimen E., Öncül A. M. T., CAMBAZOĞLU M.

Journal of the Pakistan Medical Association, vol.66, no.7, pp.880-883, 2016 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 7
  • Publication Date: 2016
  • Journal Name: Journal of the Pakistan Medical Association
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.880-883
  • Keywords: Bisphosphonates related osteonecrosis of the jaw (BRONJ), Oncologists, Questionnaire
  • Ankara Yıldırım Beyazıt University Affiliated: No

Abstract

© 2016, Pakistan Medical Association. All rights reserved.Objective: To evaluate the oncologists thoughts about the positive and adverse effects of bisphosphonates, drug holiday and the awareness about BRONJ. Methods: A written questionnaire was sent to 7 hospitals, which have oncology facilities in Ankara, Turkey. Results were evaluated as percentages. Chi Square and Kruskal Wallis H test was used to analyze the data. Results: A total of 53 oncologists replied to the questionnaire. BRONJ is the most seen complication (66%) due to bisphosphonates usage. Temporary suspension of the drug (52.8%) is the best treatment choice for this complication. Oncologists usually prefered dentist consultatation (39.6%). Conclusion: A good cooperation of oncologists and dentists is very important to prevent BRONJ.